Where I see patients (1)
My reviews
Selected research
-
A phase 1 study of the irreversible FLT3 inhibitor FF-10101 in relapsed or refractory acute myeloid leukemia.
Blood advances
-
LNK/SH2B3 as a novel driver in juvenile myelomonocytic leukemia.
Haematologica
-
FLT3 targeting in the modern era: from clonal selection to combination therapies.
International journal of hematology
Contact me
- Request appointment
- Refer a patient
- (415) 353-2421
4.9